M&T Bank Corp Novartis Ag Transaction History

M&T Bank Corp

$29.1 Billion
Q2 2024

A detailed history of M&T Bank Corp transactions in Novartis Ag stock. As of the latest transaction made, M&T Bank Corp holds 167,591 shares of NVS stock, worth $19.4 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

167,591

Previous 171,304 2.17%

Holding current value

$19.4 Million

Previous $16.6 Million 7.67%

% of portfolio

0.06%

Previous 0.06%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$92.57 - $107.37 $343,712 - $398,664	-3,713 Reduced 2.17%	167,591 $17.8 Million
Q1 2024 May 07, 2024	SELL	$95.27 - $108.47 $1.21 Million - $1.38 Million	-12,705 Reduced 6.9%	171,304 $16.6 Million
Q4 2023 Feb 06, 2024	SELL	$92.27 - $101.54 $301,353 - $331,629	-3,266 Reduced 1.74%	184,009 $18.6 Million
Q3 2023 Nov 02, 2023	SELL	$94.73 - $105.13 $1.25 Million - $1.39 Million	-13,224 Reduced 6.6%	187,275 $19.1 Million
Q2 2023 Aug 09, 2023	SELL	$92.52 - $104.91 $177,915 - $201,741	-1,923 Reduced 0.95%	200,499 $20.2 Million
Q1 2023 May 11, 2023	SELL	$80.03 - $92.81 $369,018 - $427,946	-4,611 Reduced 2.23%	202,422 $18.6 Million
Q4 2022 Feb 13, 2023	SELL	$75.55 - $92.52 $7.11 Million - $8.71 Million	-94,135 Reduced 45.47%	112,892 $10.2 Million
Q4 2022 Feb 13, 2023	BUY	$75.55 - $92.52 $7.11 Million - $8.71 Million	94,141 Added 83.39%	207,033 $18.8 Million
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $329,253 - $385,078	4,413 Added 2.18%	207,027 $15.6 Million
Q2 2022 Aug 05, 2022	BUY	$80.52 - $93.75 $2.66 Million - $3.09 Million	32,998 Added 19.45%	202,614 $14.2 Million
Q1 2022 May 09, 2022	BUY	$80.11 - $90.62 $1.18 Million - $1.34 Million	14,749 Added 9.52%	169,616 $14.9 Million
Q4 2021 Feb 07, 2022	SELL	$79.7 - $88.13 $4.35 Million - $4.81 Million	-54,576 Reduced 26.06%	154,867 $13.5 Million
Q3 2021 Oct 28, 2021	BUY	$81.78 - $95.14 $368,173 - $428,320	4,502 Added 2.2%	209,443 $17.1 Million
Q2 2021 Aug 13, 2021	SELL	$85.24 - $94.15 $730,506 - $806,865	-8,570 Reduced 4.01%	204,941 $18.7 Million
Q1 2021 May 06, 2021	SELL	$83.5 - $98.47 $1.46 Million - $1.72 Million	-17,429 Reduced 7.55%	213,511 $18.3 Million
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $641,579 - $776,025	-8,218 Reduced 3.44%	230,940 $21.8 Million
Q3 2020 Nov 06, 2020	SELL	$82.14 - $91.0 $14,292 - $15,834	-174 Reduced 0.07%	239,158 $20.8 Million
Q2 2020 Jul 29, 2020	BUY	$80.93 - $91.1 $343,709 - $386,901	4,247 Added 1.81%	239,332 $20.9 Million
Q1 2020 May 14, 2020	BUY	$70.67 - $99.01 $394,621 - $552,871	5,584 Added 2.43%	235,085 $19.4 Million
Q4 2019 Feb 07, 2020	SELL	$84.35 - $95.37 $66,299 - $74,960	-786 Reduced 0.34%	229,501 $21.7 Million
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $244,045 - $268,923	-2,853 Reduced 1.22%	230,287 $20 Million
Q2 2019 Aug 12, 2019	SELL	$75.4 - $92.8 $312,759 - $384,934	-4,148 Reduced 1.75%	233,140 $21.3 Million
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $26,361 - $30,152	350 Added 0.15%	237,288 $22.8 Million
Q4 2018 Feb 01, 2019	SELL	$73.66 - $82.02 $225,031 - $250,571	-3,055 Reduced 1.27%	236,938 $20.3 Million
Q3 2018 Nov 09, 2018	SELL	$66.94 - $77.43 $107,304 - $124,120	-1,603 Reduced 0.66%	239,993 $20.7 Million
Q2 2018 Aug 10, 2018	SELL	$64.91 - $73.36 $182,721 - $206,508	-2,815 Reduced 1.15%	241,596 $18.3 Million
Q1 2018 May 04, 2018	SELL	$70.39 - $84.15 $876,285 - $1.05 Million	-12,449 Reduced 4.85%	244,411 $19.8 Million
Q4 2017 Feb 06, 2018	SELL	$72.33 - $77.64 $318,975 - $342,392	-4,410 Reduced 1.69%	256,860 $21.6 Million
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $448,324 - $467,251	6,047 Added 2.37%	261,270 $22.4 Million
Q2 2017 Aug 11, 2017	BUY	N/A	255,223	255,223 $21.3 Million

Others Institutions Holding NVS

# of Institutions

1,426

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.54M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $249B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account